You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 2
  • 313 EDIT-202, a multiplexed AsCas12a edited iPSC differentiated iNK, displays a mature phenotype, high KIR expression, and ADCC towards multiple solid tumor lines

Article info

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Cell Therapies
313 EDIT-202, a multiplexed AsCas12a edited iPSC differentiated iNK, displays a mature phenotype, high KIR expression, and ADCC towards multiple solid tumor lines
Free

Authors

Citation

Allen A, Izzo K, Jagdale M, et al
313 EDIT-202, a multiplexed AsCas12a edited iPSC differentiated iNK, displays a mature phenotype, high KIR expression, and ADCC towards multiple solid tumor lines
Journal for ImmunoTherapy of Cancer 2022;10:doi: 10.1136/jitc-2022-SITC2022.0313

Publication history

  • First published November 7, 2022.
Online issue publication 
April 26, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.